So after all that you agree that the 'rules' have created the issue, but maintain that it's the same as having no rules. That makes absolutely no sense. If there was no barrier to copying the delivery system, Mylar would be punished by the market for drastically raising its prices. The FDA makes matters worse by classifying epipens as both a drug and a medical device. This means that as generic versions become available doctors will be prohibited from making an equivalent prescription.
The government and its champions can scream like stuck pigs all they want, but the government is the source of this problem.
The government and its champions can scream like stuck pigs all they want, but the government is the source of this problem.
